Clinical Research Directory
Browse clinical research sites, groups, and studies.
Locally Optimised Contouring With AI Technology for Radiotherapy
Sponsor: Royal North Shore Hospital
Summary
LOCATOR is a multicentre phase II randomised clinical trial that is looking at the process of contouring in radiation treatment for breast cancer patients. This study looks at whether contouring aided by artificial intelligence (AI) is comparable in quality to that of contouring done completely manually by a radiation oncologist. We are also looking at whether AI assisted contouring saves radiation oncologists time when compared to fully manual contouring. LOCATOR uses the LOCATOR software which is an in-house software developed locally and trained on local data.
Official title: LOCATOR - Locally Optimised Contouring With AI Technology for Radiotherapy
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
444
Start Date
2025-02-11
Completion Date
2030-04-30
Last Updated
2026-01-29
Healthy Volunteers
Yes
Interventions
AI assisted contouring
Initial are generated automatically using software powered by artificial intelligence
Locations (3)
Western Cancer Centre Dubbo
Dubbo, New South Wales, Australia
Central West Cancer Centre
Orange, New South Wales, Australia
Department of Radiation Oncology, Royal North Shore Hospital
St Leonards, New South Wales, Australia